论文部分内容阅读
目的通过对比分析硝苯地平早产治疗中的临床应用价值。方法选取2012年2月~2013年4月期间本院妇产科收治的56例有早产先兆的单胎初产妇作为本组研究的观察对象,将所有产妇按照治疗干预方式分为观察组与对照组,观察组27例产妇给予硝苯地平治疗,对照组29例产妇给予硫酸镁治疗,比较两种干预方法在早产治疗中的临床效果。结果观察组分娩推迟时间明显长于对照组,两组相比差异具有统计学意义(P<0.05);观察组的新生儿情况明显优于对照组,且治疗中的不良反应也明显少于对照组。结论硝苯地平在早产的临床治疗中表现出良好的安全性,能够有效推迟分娩时间,可以作为抑制宫缩药物在临床中推广使用。
Objective To compare the clinical value of nifedipine preterm delivery. Methods From February 2012 to April 2013 in our hospital obstetrics and gynecology admitted to 56 cases of single mothers with preterm labor as a premonitory object of observation in this study, all maternal treatment interventions were divided into observation group and control group In the observation group, 27 maternal women were treated with nifedipine, while 29 maternal women in the control group were treated with magnesium sulfate. The clinical effects of the two interventions in preterm labor were compared. Results The delayed delivery time of the observation group was significantly longer than that of the control group, the difference between the two groups was statistically significant (P <0.05); the neonatal situation in the observation group was significantly better than that of the control group, and the adverse reactions in the treatment group were also significantly less than those in the control group . Conclusion Nifedipine shows good safety in the clinical treatment of premature delivery, which can effectively delay the delivery time and can be used as a medicine to inhibit uterine contractions in clinical practice.